What is Equinox Group?
Equinox Group operates as a client-centered boutique consulting firm, specializing in creative problem-solving for pharmaceutical and biotechnology companies. The firm collaborates with clinical, research, commercial, and marketing teams to inform R&D decisions across all stages of development. Equinox Group distinguishes itself through an objective, quantitative approach, carving out a unique niche within the healthcare consulting landscape.
How much funding has Equinox Group raised?
Equinox Group has raised a total of $325K across 2 funding rounds:
Debt
$150K
Debt
$175K
Debt (2020): $150K with participation from PPP
Debt (2021): $175K led by PPP
What's next for Equinox Group?
The large-scale late-stage funding indicates Equinox Group is poised for significant expansion and strategic initiatives. This capital infusion will likely fuel further development of their analytical tools, enhance service offerings to a broader client base within the life sciences, and potentially support market penetration into new therapeutic areas or geographical regions. The company's focus on data-driven solutions positions it well to capitalize on evolving R&D landscapes.
See full Equinox Group company page
